Last edition
News about "knee osteoarthritis treatment "
Croma-Pharma Acquires Synocrom, Re-Enters Orthopaedics
Croma-Pharma acquires Synocrom to re-enter orthopaedics, expanding its portfolio with a hyaluronic acid treatment for knee osteoarthritis launching in the EU and Switzerland in May 2026.
Knee Osteoarthritis Treatment | 10/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members